Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: Statistical analysis of all published cases and literature review

References

• Hubscher SC, Lumley MA, Elias E. Vanishing bile duct syndrome: A possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 1993; 17: 70–7
   PubMed Web of Science ®Google Scholar
• Rossini M, Lorand-Metze I, Oliveira G, De Souza C. Vanishing bile duct syndrome in Hodgkin's disease: Case report. Sao Paulo Med J 2000; 118: 154–7
   PubMedGoogle Scholar
• Gottrand F, Cullu F, Mazingue F, Nelken B, Lecomte-Houcke M, Farriaux JP. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease. J Pediatr Gastroenterol Nutr 1997; 24: 430–3
   PubMedGoogle Scholar
• Rodriguez-Gil FJ, Rincon-Fuentes JP, Garcia-Perez B, Conesa-Pallares FJ, Vicente-Lopez JJ, Grau-Garcia FJ, et al. Idiopathic cholestasis associated with bloody diarrhea as the first manifestation of Hodgkin's lymphoma. Gastroeneterol Hepatol 2006; 29: 240–3
   PubMedGoogle Scholar
• Parcero SA, Rubio RE, Huberman ED. Idiopathic cholestasis in Hodgkin's disease. Acta Gastroenterol Latinoam 1980; 10: 283–9
   PubMedGoogle Scholar
• Levitan R, Diamond HD, Craver LF. Jaundice in Hodgkin's disease. Am J Med 1961; 30: 99–111
   PubMedGoogle Scholar
• Bouroncle B, Old J, Vazques A. Pathogenesis of jaundice in Hodgkin's disease. Arch Intern Med 1962; 110: 872–83
   PubMedGoogle Scholar
• Juniper K. Prolonged severe obstructive jaundice in Hodgkin's disease. Gastroenterology 1963; 44: 199–204
   PubMedGoogle Scholar
• Groth C, Hellstrom K, Hofvendahl S, Nordenstam H, Wengle B. Diagnosis of malignant lymphoma at laparotomy disclosing intrahepatic cholestasis. Acta Chir Scand 1972; 138: 186–9
   PubMedGoogle Scholar
• Perera D, Greene M, Fenster L. Cholestasis associated with extrabiliary Hodgkin's disease. Gastroenterology 1974; 67: 680–5
   PubMed Web of Science ®Google Scholar
• Piken E, Abraham G, Hepner G. Investigation of a patient with Hodgkin's disease and cholestasis. Gastroenterology 1979; 77: 145–7
   PubMedGoogle Scholar
• Trewby PN, Portmann B, Brinkley DM, Williams R. Liver disease as presenting manifestation of Hodgkin's disease. Quart J Med 1979; 189: 137–50
   Google Scholar
• Lieberman D. Intrahepatic cholestasis due to Hodgkin's disease. J Clin Gastroenterol 1986; 8: 304–7
   PubMed Web of Science ®Google Scholar
• Birrer M, Young R. Differential diagnosis of jaundice in lymphoma patients. Sem Liver Disease 1987; 7: 269–77
   PubMedGoogle Scholar
• Cordoba Iturriagagoitia A, Inarrairaegui Bastarrica M, Perez de Equiza E, Zosaya Urmeneta JM, Marinez-Penuela JM, Beloqui Perez R. Ductal regeneration in vanishing bile duct syndrome in Hodgkin's lymphoma. Gastroenterol Hepatol 2005; 28: 275–8
   PubMedGoogle Scholar
• Yusuf MA, Elias E, Hubscher SG. Jaundice caused by the vanishing bile duct syndrome in a child with hodgkin lymphoma. J Pediatr Hematol Oncol 2000; 22: 154–7
   PubMedGoogle Scholar
• Crosbie OM, Crown JP, Nolan NP, Murray R, Hegarty JE. Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease. Hepatology 1997; 26: 5–8
   PubMed Web of Science ®Google Scholar
• de Medieros BC, Lacerda MA, Telles JE, da Silva JA, de Medieros CR. Cholestasis secondary to Hodgkin's disease: Report of 2 cases of vanishing bile duct syndrome. Haematologica 1998; 83: 1038–40
   PubMedGoogle Scholar
• Allory Y, Metreau J, Zafrani E. Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin's disease. Ann Pathol 2000; 20: 52–5
   PubMedGoogle Scholar
• Ozkan A, Yoruk A, Celkan T, Apak J, Yildiz I, Ozbay G. The vanishing bile duct syndrome in a child with Hodgkin disease. Med Pediatr Oncol 2001; 36: 398–9
   PubMedGoogle Scholar
• Kormurcu S, Ozet A, Altundag MK, Arpaci F, Ozturk B, Celasun B, et al. Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease. Ann Hematol 2002; 81: 57–8
   PubMedGoogle Scholar
• Ripoll C, Carretero L, Sabin P, Alvarez E, Marrupe D, Banares R. Idiopathic cholestasis associated with progressive ductopenia in two patients with Hodgkin's disease. Gastroenterol Hepatol 2002; 25: 313–5
   PubMedGoogle Scholar
• Guliter S, Erdem O, Isik M, Yamac K, Uluoglu O. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: Report of a case. Tumori 2004; 90: 517–20
   PubMedGoogle Scholar
• Han WS, Jung ES, Kim YH, et al. Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma. Korean J Hepatol 2005; 11: 164–8
   PubMedGoogle Scholar
• Schmitt A, Gilden DJ, Saint S, Moseley R. Empirically incorrect. N Engl J Med 2006; 354: 509–14
   PubMedGoogle Scholar
• Barta SK, Yahalom J, Shia J, Hamlin P. Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma. Clin Lymphoma Myeloma 2006; 7: 77–82
   PubMedGoogle Scholar
• Warner AS, Whitcomb FF. Extrahepatic Hodgkin's disease and cholestasis. Am J Gastroenterol 1986; 8: 304–7
   Google Scholar
• Jansen PL, van der Lelie H. Intrahepatic cholestasis and biliary cirrhosis associated with extrahepatic Hodgkin's disease. Neth J Med 1994; 44: 99–102
   PubMedGoogle Scholar
• Yalcin S, Kars A, Sokmensuer C, Atahan L. Extrahepatic Hodgkin's disease with intrahepatic cholestasis: Report of two cases. Oncology 1999; 57: 83–5
   PubMed Web of Science ®Google Scholar
• Liangpunsakul S, Kwo P, Koukoulis GK. Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury. Eur J Gastroenterol Hepatol 2002; 14: 323–7
   PubMed Web of Science ®Google Scholar
• Cavalli G, Casali AM, Lambertini F, Busachi C. Changes in the small biliary passages in the hepatic localization of Hodgkin's disease. Virchows Arch [A] 1979; 384: 295–306
   PubMedGoogle Scholar
• Lefkowitch JH, Falkow S, Whitlock RT. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure. Arch Pathol Lab Med 1985; 109: 424–6
   PubMed Web of Science ®Google Scholar
• Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet 1987; 2: 493–6
   PubMedGoogle Scholar
• Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, et al. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: Long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. J Clin Oncol 2006; 24: 3128–35
   PubMed Web of Science ®Google Scholar